{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/1b454f3a-002e-540e-82a0-3e5bcb0b5da9/6a466fb80408b74287c0ee55?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Examining fronto-limbic brain and sleep mechanisms of antidepressant effects in cognitive-behavioral therapy for insomnia","description":"<p>Insomnia and depression are two serious and debilitating conditions. Insomnia on its own is linked to an increase in suicide risk, and insomnia can also exacerbate the severity of depression.</p><p><br></p><p>Andrea Goldstein-Piekarski, assistant professor in the department of psychiatry and behavioral sciences at Stanford, and Adam Krause, post-doctoral research fellow in Stanford’s psychiatry department, are two of the authors of a recent study in the journal Neuropsychopharmacology. Cognitive behavioral therapy for insomnia, or CBTI, is the gold standard for treating insomnia, and it’s been shown to relieve depressive symptoms as well.</p><p><br></p><p>Read the full study here: https://www.nature.com/articles/s41386-026-02431-0</p>","author_name":"Springer Nature"}